Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 9
1966 7
1967 13
1968 16
1969 14
1970 14
1971 14
1972 21
1973 22
1974 29
1975 57
1976 45
1977 45
1978 54
1979 59
1980 53
1981 58
1982 65
1983 88
1984 52
1985 68
1986 61
1987 75
1988 72
1989 57
1990 85
1991 72
1992 81
1993 81
1994 88
1995 104
1996 97
1997 96
1998 66
1999 72
2000 63
2001 59
2002 54
2003 54
2004 65
2005 61
2006 50
2007 67
2008 60
2009 47
2010 58
2011 48
2012 52
2013 59
2014 49
2015 54
2016 44
2017 42
2018 32
2019 49
2020 40
2021 36
2022 36
2023 30
2024 27
2025 33
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,038 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics of indomethacin.
Alván G, Orme M, Bertilsson L, Ekstrand R, Palmér L. Alván G, et al. Clin Pharmacol Ther. 1975 Sep;18(3):364-73. doi: 10.1002/cpt1975183364. Clin Pharmacol Ther. 1975. PMID: 1100305 Clinical Trial.
In 8 other normal subjects and in 5 patients a 50-mg oral dose of indomethacin was given and the indomethacin concentration was followed from 8 to 32 hr after dosing. ...After oral and rectal doses the plasma decay of indomethacin was biphasic, and the data w …
In 8 other normal subjects and in 5 patients a 50-mg oral dose of indomethacin was given and the indomethacin concentration wa …
Indomethacin sustained-release?
Green JA. Green JA. Drug Intell Clin Pharm. 1984 Dec;18(12):1004-7. doi: 10.1177/106002808401801222. Drug Intell Clin Pharm. 1984. PMID: 6391883 Review.
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulation. The literature on indomethacin was examined with respect to the above conditions and it was concluded that its marketing as a sust …
When neither of these conditions is satisfied, then a sustained-release preparation may offer no advantages over the conventional formulatio …
A comparative clinical trial of fenbufen and indomethacin in patients with rheumatoid arthritis.
Vergara-Castro JM, Arias LF, Greenberg BP. Vergara-Castro JM, et al. J Int Med Res. 1976;4(6):418-26. doi: 10.1177/030006057600400607. J Int Med Res. 1976. PMID: 800381 Clinical Trial.
A 12-week double-blind crossover trial compared fenbufen and indomethacin in 40 patients with rheumatoid arthritis. Fenbufen (600-800 mg/day) was significantly superior to indomethacin (75-100 mg/day) in improving the physical measurements of rheumatoid arthritis ac …
A 12-week double-blind crossover trial compared fenbufen and indomethacin in 40 patients with rheumatoid arthritis. Fenbufen (600-800 …
Indomethacin--aspirin interaction: a clinical appraisal.
Brooks PM, Walker JJ, Bell MA, Buchanan WW, Rhymer AR. Brooks PM, et al. Br Med J. 1975 Jul 12;3(5975):69-71. doi: 10.1136/bmj.3.5975.69. Br Med J. 1975. PMID: 1095133 Free PMC article. Clinical Trial.
Plasma profiles of indomethacin after a 50-mg oral dose were constructed in six healthy volunteers before and after a week of aspirin treatment. Aspirin did not interfere with indomethacin plasma levels. To examine the clinical effect of concurrent indomethacin …
Plasma profiles of indomethacin after a 50-mg oral dose were constructed in six healthy volunteers before and after a week of aspirin …
Indomethacin in migraine.
Anthony M, Lance JW. Anthony M, et al. Med J Aust. 1968 Jan 13;1(2):56-7. doi: 10.5694/j.1326-5377.1968.tb27465.x. Med J Aust. 1968. PMID: 4867513 Clinical Trial. No abstract available.
Indomethacin increases plasma lithium.
Frölich JC, Leftwich R, Ragheb M, Oates JA, Reimann I, Buchanan D. Frölich JC, et al. Br Med J. 1979 Apr 28;1(6171):1115-6. doi: 10.1136/bmj.1.6171.1115. Br Med J. 1979. PMID: 444956 Free PMC article. Clinical Trial.
After steady-state plasma lithium concentrations had been reached, the subjects received indomethacin placebo for three to seven days, indomethacin (50 mg thrice daily) for seven days, and placebo again for three to seven days. Indomethacin increased plasma l …
After steady-state plasma lithium concentrations had been reached, the subjects received indomethacin placebo for three to seven days …
The efficiency and safety of low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonate: a randomized controlled trial.
Hongkan W, Petarwut N, Siriporn T, Thamwiriyakul N, Durongbhandhu T. Hongkan W, et al. Sci Rep. 2025 Nov 11;15(1):39530. doi: 10.1038/s41598-025-23285-4. Sci Rep. 2025. PMID: 41219369 Free PMC article. Clinical Trial.
This study aimed to compare the efficacy and safety of low-dose intravenous indomethacin (two doses) with the conventional three-dose for the closure of PDA in preterm neonates. ...The patients were randomized into 2 groups: Group 1, 64 patients received 2 doses of indo …
This study aimed to compare the efficacy and safety of low-dose intravenous indomethacin (two doses) with the conventional three-dose …
Clinical Response of Paracetamol versus Indomethacin in the Medical Treatment of Patent Ductus Arteriosus in Newborn.
Tazmin T, Islam MN, Ali MA, Hossain MA, Dhar SK, Ferdousi J, Sharmin M, Begum K, Mahbub KNM, Belayet TB, Kar N, Fahmin F, Jahan A, Bhuiyan SA, Ahmed A. Tazmin T, et al. Mymensingh Med J. 2025 Oct;34(4):1057-1062. Mymensingh Med J. 2025. PMID: 41024542 Clinical Trial.
The paracetamol group's PDA closure rate was 85.7%, whereas the indomethacin group's was 85.2%. More increase of serum creatinine and serum bilirubin and reduction of platelet count were observed in indomethacin group after intervention but these differences were no …
The paracetamol group's PDA closure rate was 85.7%, whereas the indomethacin group's was 85.2%. More increase of serum creatinine and …
Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.
Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH, et al. Ment LR, et al. Pediatrics. 1994 Apr;93(4):543-50. Pediatrics. 1994. PMID: 8134206 Clinical Trial.
Sixteen indomethacin-treated neonates and 29 control neonates died (P = .08); there was a difference favoring indomethacin with respect to survival time (P = .06). ...There were no differences in adverse events attributed to indomethacin between the two treat …
Sixteen indomethacin-treated neonates and 29 control neonates died (P = .08); there was a difference favoring indomethacin wit …
Indomethacin: a survey of clinical trials.
O'Brien WM. O'Brien WM. Clin Pharmacol Ther. 1968 Jan-Feb;9(1):94-107. doi: 10.1002/cpt19689194. Clin Pharmacol Ther. 1968. PMID: 4866775 Review. No abstract available.
3,038 results